A clinical evaluation of sustained release metoprolol durules in the treatment of angina pectoris
- 1 February 1982
- journal article
- clinical trial
- Published by Wiley in Clinical Cardiology
- Vol. 5 (2) , 131-135
- https://doi.org/10.1002/clc.4960050203
Abstract
A clinical comparison of the sustained release form of metoprolol, consisting of a 200 mg metoprolol durule, with 100 mg conventional metoprolol twice daily, has been carried out to assess the therapeutic control of ten patients with stable angina pectoris. Objective measurements of heart rate, blood pressure, and ECG recordings were assessed during exercise on a bicycle ergometer. Ten patients completed the 8-week double-blind study. There were similar changes in heart rate and blood pressure at rest and during exercise, both at 2 h and at 12 and 24 h postdose. Although similar exercise tolerance was achieved on both regimes, there was significantly less ST-segment depression at 24 h post durule, in comparison with the 12 h post conventional metoprolol reading, suggesting that metoprolol durules produce a more effective reduction in the degree of myocardial ischemia.Keywords
This publication has 9 references indexed in Scilit:
- Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.BMJ, 1980
- Diagnostic value of routine exercise testing in hospital patients with angina pectoris.BMJ, 1979
- Stress testing: Clinical application and predictive capacityProgress in Cardiovascular Diseases, 1979
- Once daily administration of sustained release propranolol capsules in the treatment of angina pectorisEuropean Journal of Clinical Pharmacology, 1979
- An eighteen months' study of the clinical response to metoprolol, a selective α1-receptor blocking agent, in patients with angina pectorisPublished by Oxford University Press (OUP) ,1976
- Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.Heart, 1976
- Assessment of Metoprolol, a Cardioselective Beta-Blocking Agent, during Chronic Therapy in Patients with Angina PectorisJournal of International Medical Research, 1976
- Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.Heart, 1974
- Effects of single doses of alprenolol and two cardioselective ?-blockers (H 87/07 and H 93/26) on exercise-induced angina pectorisEuropean Journal of Clinical Pharmacology, 1974